Melanoma Patients with Unknown Primary Site or Nodal Recurrence after Initial Diagnosis Have a Favourable Survival Compared to Those with Synchronous Lymph Node Metastasis and Primary Tumour-Reference-Cited by-同舟云学术

Melanoma Patients with Unknown Primary Site or Nodal Recurrence after Initial Diagnosis Have a Favourable Survival Compared to Those with Synchronous Lymph Node Metastasis and Primary Tumour

Published:2013-06-25 Issue:6 Volume:8 Page:e66953
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Weide Benjamin,Faller Christine,Elsässer Margrit,Büttner Petra,Pflugfelder Annette,Leiter Ulrike,Eigentler Thomas Kurt,Bauer Jürgen,Meier Friedegund,Garbe Claus

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference43 articles.

1. Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases;CM Balch;J Clin Oncol,2010

2. Final version of 2009 AJCC melanoma staging and classification;CM Balch;J Clin Oncol,2009

3. Is detection of melanoma metastasis during surveillance in an early phase of development associated with a survival benefit?;U Leiter;Melanoma Res,2010

4. Prognosis of sentinel node staged patients with primary cutaneous melanoma;O Elsaesser;PLoS ONE,2012

5. A novel and accurate computer model of melanoma prognosis for patients staged by sentinel lymph node biopsy: comparison with the American Joint Committee on Cancer model;GG Callender;J Am Coll Surg,2012

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A patient with rapidly growing axillary masses;JAAPA;2023-07

2. Neoadjuvant ipilimumab plus nivolumab in synchronous clinical stage III melanoma;European Journal of Cancer;2021-05

3. Melanoma of unknown primary: New perspectives for an old story;Critical Reviews in Oncology/Hematology;2021-02

4. Clinicopathological Features, Staging, and Current Approaches to Treatment in High-Risk Resectable Melanoma;JNCI: Journal of the National Cancer Institute;2020-02-15

5. Melanoma Prognosis and Staging;Cutaneous Melanoma;2020